Riley Jennifer has filed 3 insider transactions across 1 company since January 2025.
Most recent transaction: a grant/award of 95000 shares of Avalo Therapeutics, Inc. ($AVTX) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Avalo Therapeutics, Inc. | $AVTX | Riley Jennifer | Chief Strategy Officer | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 18,133,968 | 9999.99% | 0.52% |
| Dec. 10, 2025 | Avalo Therapeutics, Inc. | $AVTX | Riley Jennifer | Chief Strategy Officer | F | Common Stock | 637 | $4.10 | 2,655.0000 | 18,133,968 | 19.35% | 0.00% |
| Jan. 1, 2025 | Avalo Therapeutics, Inc. | $AVTX | Riley Jennifer | Chief Strategy Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |